index-visual

Operating Committee

The Operating Committee manages the day-to-day operations of the NTI, encompassing the following areas.

  • Knowledge of nanotechnology
  • Expertise in new nanotechnology and company development
  • Workforce development
  • Individual accomplishment and credibility in research and development for nanotechnology and nano-biotechnology

Operating Oversight Committee Members

Anthony Green, Ph.D.
Ben Franklin Director, NTI
Vice President of Technology Commercialization: Life Sciences, BFTP/SEP
anthony@sep.benfranklin.org
(215) 972-6700 x3713

Robert Carpick, Ph.D.
University of Pennsylvania Principal Investigator, NTI
Professor of Mechanical Engineering and Applied Mechanics, University of Pennsylvania
carpick@seas.upenn.edu
215-898-4608

Kambiz Pourrezaei, Ph.D.
Drexel University Principal Investigator, NTI
Professor, School of Biomedical Engineering and Health Sciences, Drexel University
pourrezk@drexel.edu
(215) 895-2260

Erli Chen, Ph.D.
Director, Nanotechnology Commercialization Group, NTI
Director of Nanotechnology Licensing, Center for Technology Transfer, University of Pennsylvania
chener@ctt.upenn.edu
(215) 898-9272

Why Is Small So Big?

Nanotechnology deals with products and processes that are measured in almost unbelievably small increments called “nanometers”—one billionth of a meter.

At the nanoscale, materials differ from larger objects in their physical, chemical and biological properties; therefore, they lend themselves to new and improved materials, systems and devices. Nanotechnology is behind the development of such diverse advancements as:

  1. Drug Delivery
  2. Biofiltration and Separation sciences
  3. Improved coatings for medical devices

Thanks to rapid advances in this exciting new field, we now have the tools and talents to manipulate materials on the molecular scale—a technology literally changing the world as we know it.